NovaBridge Biosciences (NBP) Inventory Average (2022)
NovaBridge Biosciences (NBP) posted quarterly Inventory Average of $7.6 million for Q4 2022, down 99.64% on a QoQ basis from $2.1 billion in Q2 2022.
NovaBridge Biosciences (NBP) Inventory Average (2022) Analysis & Trends
NovaBridge Biosciences (NBP) has reported Inventory Average for 1 consecutive years, with $7.6 million the latest figure, recorded in Q4 2022.
- Quarterly Inventory Average changed N/A year-over-year to $7.6 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $7.6 million (changed N/A YoY) and the FY2023 annual result came in at $2.8 million, down 39.16% from the prior year.
- Inventory Average fell to $7.6 million in Q4 2022 per NBP's latest filing, from $2.1 billion in the prior quarter.
- Over the last five years, Inventory Average for NBP reached as high as $2.1 billion in Q2 2022 and fell as low as $7.6 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 644.91 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.73 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 3.15 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | NovaBridge Biosciences | 389.86 Mn | 389.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 7.58 Mn |
| Jun 30, 2022 | 2.14 Bn |